Inflammatory back pain red-flag assessment
Distinguishing axial SpA from mechanical · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A structured approach to chronic back pain aimed at identifying inflammatory features of axial spondyloarthritis while screening for sinister causes. Inflammatory back pain is characteristically insidious, improves with exercise not rest, causes night pain and prolonged morning stiffness in a young adult.
Red flags
- Thoracic pain, fever or weight loss (infection/malignancy)
- Progressive neurological deficit or saddle anaesthesia (cauda equina)
- New back pain over 50 or history of cancer
- Night pain not relieved by position with systemic upset
- Bladder/bowel dysfunction
Assessment
Differential diagnosis
- Mechanical / degenerative back pain
- Axial spondyloarthritis (ankylosing spondylitis)
- Vertebral infection (discitis/osteomyelitis)
- Malignant cord compression / metastases
- Osteoporotic vertebral fracture
- Cauda equina syndrome
Investigations
- Inflammatory markers (CRP/ESR)
- HLA-B27
- MRI sacroiliac joints and spine (bone marrow oedema / sacroiliitis)
- Pelvic/sacroiliac radiographs
- Bloods for infection/malignancy if red flags (FBC, calcium, PSA, myeloma screen)
- Urgent MRI whole spine if neurological red flags
Management
- Apply the inflammatory back pain criteria: onset <45 years, insidious, >3 months, morning stiffness >30 min, improves with exercise, night pain, buttock pain
- Screen for sinister red flags (infection, malignancy, fracture, cauda equina) and act urgently if present
- Examine spinal mobility (Schober test) and check for enthesitis, dactylitis, psoriasis, uveitis and IBD
- Check CRP/ESR and HLA-B27
- Arrange MRI sacroiliac joints as the key imaging test for early axial SpA
- Refer suspected axial SpA to rheumatology promptly to shorten diagnostic delay
- Start regular NSAIDs and a structured exercise/physiotherapy programme
- Escalate to biologic therapy via rheumatology if NSAID-refractory active disease
Drugs & doses
Naproxen — 500 mg PO BD (with gastroprotection) as first-line for axial SpA
Etoricoxib — 90 mg PO OD as alternative NSAID
Adalimumab — 40 mg SC every 2 weeks for NSAID-refractory active axial SpA (specialist)
Secukinumab — 150 mg SC monthly (after loading) as IL-17 inhibitor option
Disposition
Outpatient rheumatology referral for suspected axial SpA; urgent imaging/admission if infective, malignant or cauda equina red flags.
Complications & pitfalls
- Delayed diagnosis of axial SpA (years of avoidable disability)
- Spinal ankylosis and fracture risk if untreated
- Missed infection or malignancy
- Acute anterior uveitis
- Chronic pain and reduced function
Exam pearls
- Improvement with exercise and worsening with rest is the hallmark distinguishing inflammatory from mechanical pain
- MRI sacroiliac joints detects sacroiliitis before radiographic change - do not rely on plain films
- HLA-B27 supports but does not confirm the diagnosis
- Average diagnostic delay in axial SpA is years - prompt referral matters
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.